Biomedical Engineering Reference
In-Depth Information
[133] Coles, D.J., et al., “The characterization of a novel dendritic system for gene delivery by
isothermal titration calorimetry,”
Biopolymers
, Vol. 90, No. 5, 2008, pp. 651-4.
[134] Kim, T.I., et al., “Synthesis and characterization of a novel arginine-grafted dendritic block
copolymer for gene delivery and study of its cellular uptake pathway leading to
transfection,”
Bioconjug Chem
, Vol. 18, No. 2, 2007, pp. 309-17.
[135] Meade, B.R., and Dowdy, S.F., “Enhancing the cellular uptake of siRNA duplexes
following noncovalent packaging with protein transduction domain peptides,”
Adv Drug
Deliv Rev
, Vol. 60, No. 4-5, 2008, pp. 530-6.
[136] Simeoni, F., et al., “Insight into the mechanism of the peptide-based gene delivery system
MPG: implications for delivery of siRNA into mammalian cells,”
Nucleic Acids Res
, Vol.
31, No. 11, 2003, pp. 2717-24.
[137] Davidson, T.J., et al., “Highly efficient small interfering RNA delivery to primary
mammalian neurons induces MicroRNA-like effects before mRNA degradation,”
J
Neurosci
, Vol. 24, No. 45, 2004, pp. 10040-6.
[138] Zhang, C., et al., “siRNA-containing liposomes modified with polyarginine effectively
silence the targeted gene,”
J Control Release
, Vol. 112, No. 2, 2006, pp. 229-39.
[139] Law, M., Jafari, M., and Chen, P., “Physicochemical characterization of siRNA-peptide
complexes,”
Biotechnol Prog
, Vol. 24, No. 4, 2008, pp. 957-63.
[140] Muratovska, A., and Eccles, M.R., “Conjugate for efficient delivery of short interfering
RNA (siRNA) into mammalian cells,”
FEBS Lett
, Vol. 558, No. 1-3, 2004, pp. 63-8.
[141] Nakamura, Y., et al., “Octaarginine-modified multifunctional envelope-type nano device
for siRNA,”
J Control Release
, Vol. 119, No. 3, 2007, pp. 360-7.
[142] Moschos, S.A., et al., “Lung delivery studies using siRNA conjugated to TAT(48-60) and
penetratin reveal peptide induced reduction in gene expression and induction of innate
immunity,”
Bioconjug Chem
, Vol. 18, No. 5, 2007, pp. 1450-9.
[143] Moschos, S.A., Williams, A.E., and Lindsay, M.A., “Cell-penetrating-peptide-mediated
siRNA lung delivery,”
Biochem Soc Trans
, Vol. 35, No. Pt 4, 2007, pp. 807-10.
[144] Torchilin, V.P., “Targeted polymeric micelles for delivery of poorly soluble drugs,”
Cell
Mol Life Sci
, Vol. 61, No. 19-20, 2004, pp. 2549-59.
[145] Jaracz, S., et al., “Recent advances in tumor-targeting anticancer drug conjugates,”
Bioorg
Med Chem
, Vol. 13, No. 17, 2005, pp. 5043-54.
[146] Gabizon, A., et al., “Tumor cell targeting of liposome-entrapped drugs with phospholipid-
anchored folic acid-PEG conjugates,”
Adv Drug Deliv Rev
, Vol. 56, No. 8, 2004, pp. 1177-
92.
[147] Widera, A., Norouziyan, F., and Shen, W.C., “Mechanisms of TfR-mediated transcytosis
and sorting in epithelial cells and applications toward drug delivery,”
Adv Drug Deliv Rev
,
Vol. 55, No. 11, 2003, pp. 1439-66.
[148] Sawant, R.M., et al., “ “SMART” drug delivery systems: double-targeted pH-responsive
pharmaceutical nanocarriers,”
Bioconjug Chem
, Vol. 17, No. 4, 2006, pp. 943-9.
[149] Kale, A.A., and Torchilin, V.P., “Design, synthesis, and characterization of pH-sensitive
PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of
substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates,”
Bioconjug
Chem
, Vol. 18, No. 2, 2007, pp. 363-70.
[150] Kale, A.A., and Torchilin, V.P., “Enhanced transfection of tumor cells in vivo using
"Smart" pH-sensitive TAT-modified pegylated liposomes,”
J Drug Target
, Vol. 15, No. 7-
8, 2007, pp. 538-45.
[151] Sethuraman, V.A., and Bae, Y.H., “TAT peptide-based micelle system for potential active
targeting of anti-cancer agents to acidic solid tumors,”
J Control Release
, Vol. 118, No. 2,
2007, pp. 216-24.
Search WWH ::
Custom Search